Placebo (Part B)

DRUG4 trials

Sponsors

Galapagos NV, Cytokinetics, Vifor Fresenius Medical Care Renal Pharma, Cellid Co., Ltd.

Conditions

Amyotrophic Lateral SclerosisCOVID-19HyperkalemiaRenal Insufficiency, ChronicRheumatoid ArthritisVaccines

Phase 1

Safety and Immunogenicity of AdCLD-CoV19-1 OMI as a Booster: A SARS-CoV-2 (COVID-19) Preventive Vaccine

CompletedNCT05576623

Cellid Co., Ltd.COVID-19, Vaccines

Start: 2022-09-14End: 2024-02-28Updated: 2024-07-17

Phase 2

GLPG0259 in Methotrexate-refractory Rheumatoid Arthritis

CompletedNCT01211249

Galapagos NVRheumatoid Arthritis

Start: 2010-10-31End: 2011-04-30Updated: 2011-04-26

A Study to Evaluate the Effects of Multiple Doses of CK-2017357 in Patients With Amyotrophic Lateral Sclerosis (ALS)

CompletedNCT01378676

CytokineticsAmyotrophic Lateral Sclerosis

Start: 2011-06-30End: 2012-03-31Updated: 2019-05-07

Phase 3

Trial Evaluating the Efficacy and Safety of Patiromer in Chinese Subjects

CompletedNCT05136664

Vifor Fresenius Medical Care Renal PharmaHyperkalemia, Renal Insufficiency, Chronic

Start: 2022-02-10End: 2025-11-18Updated: 2026-04-13